The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. This meeting was announced in the Federal Register of June 16, 2016. The amendment is being made to reflect a change in the Procedure portion of the document. There are no other changes.
Document
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Amendment of Notice
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. This...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
81 FR 40889
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Amendment of Notice,” thefederalregister.org (June 23, 2016), https://thefederalregister.org/documents/2016-14827/pediatric-oncology-subcommittee-of-the-oncologic-drugs-advisory-committee-amendment-of-notice.